Denise R Franco Selected Research

semaglutide

1/2019	Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
1/2019	Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Denise R Franco Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2012
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 02/2012
3	Hyperglycemia 01/2020 - 02/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2019
2	Ketosis 01/2020 - 01/2019
2	Myocardial Infarction 01/2019 - 02/2012
1	Chronic Renal Insufficiency 01/2019
1	Stroke (Strokes) 01/2019

Drug/Important Bio-Agent (IBA)

3	Insulin Glargine (Lantus)FDA Link 01/2020 - 02/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2012
2	semaglutideIBA 01/2019 - 01/2019
2	Insulin (Novolin)FDA Link 02/2014 - 02/2012
1	insulin degludecIBA 01/2019
1	KetonesIBA 01/2019
1	Insulin Detemir (Levemir)FDA Link 01/2019
1	Insulin Aspart (NovoLog)FDA Link 01/2019
1	antineoplaston A10 (A 10)IBA 02/2014
1	Isophane Insulin (NPH Insulin)FDA Link 02/2012
1	Calcium Gluconate (CBG)IBA 02/2012

Therapy/Procedure

2	Glycemic Control 01/2020 - 02/2012
1	Therapeutics 01/2019